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Abstract 
Purpose: Evidence suggests that breast feeding may decrease the risk of epithelial ovarian 
cancer but it is not clear whether there is a relationship with duration of breast feeding, 
patterns of breast feeding, or particular histological subtypes of ovarian cancer. We 
sought to investigate these issues in detail. 
Methods:  Data from participants in a population-based study of ovarian cancer in 
western Washington State, USA (2002-2007) who had had at least one birth (881cases 
and 1,345 controls) were used to assess relations between patterns of breast feeding and 
ovarian cancer. Logistic regression was used to calculate odds ratios (OR) and 95% 
confidence intervals (CI). 
Results: Women who ever breast fed had a 22% reduction in risk of ovarian cancer 
compared with those who never breast fed (OR=0.78, 95%CI 0.64-0.96) and risk 
reduction appeared greater with longer durations of feeding per child breast fed 
(OR=0.56, 95%CI 0.32-0.98 for 18 months average duration breast feeding versus none). 
Introduction of supplementary feeds did not substantially alter these effects. The overall 
risk reduction appeared greatest for the endometrioid and clear cell subtypes (OR per 
month of average breast feeding per child breast fed=0.944, 95%CI 0.903-0.987). 
Conclusions: Amongst women who have had the opportunity to breast feed, ever breast 
feeding and increasing durations of episodes of breast feeding for each breast-fed child 
are associated with a decrease in the risk of ovarian cancer independent of numbers of 
births, which may be strongest for the endometrioid subtype.  
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Introduction 
 
The weight of evidence strongly suggests a role for ovulation or associated reproductive 
hormones in the development of epithelial ovarian cancer[1,2] and as breast feeding can 
have substantial impact upon both of these [3], it might be expected to influence ovarian 
cancer risk. Indeed, a meta-analysis of nine case-control studies published prior to 2004 
found that women who had ever breast fed had a 30% reduction in risk of ovarian 
cancer[4] and more recent publications have supported this finding[5-9]. What is less 
clear is how the duration of breast feeding influences ovarian cancer risk and whether 
factors such as the timing of introduction of supplementary feeds can modify the 
relationship. It has also been suggested that other variations in breast feeding practices 
such as the number of children breast fed [10,11]or whether the last born child is breast 
fed may influence the effect of lactation on ovarian cancer risk[9]. 
Clarification of these issues is required in order to be able to provide women with the best 
advice about the possible preventive benefits of breast feeding. We therefore sought to 
explore in depth the relationship between ovarian cancer and breast feeding using data 
from a large case-control study based in Washington State, USA. 
 
Materials and Methods 
 
Female residents of a thirteen-county area of western Washington State, USA who were 
diagnosed with a primary invasive or borderline epithelial ovarian tumor from 2002 
through 2007 were eligible for the study. From 2002-2005, women aged 35-74 years 
were included, while in 2006-2007 only women of ages 35-69 years were included.  Case 
women were identified through the Cancer Surveillance System (CSS), a population-
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based registry that is part of the Surveillance, Epidemiology, and End Results (SEER) 
program of the US National Cancer Institute.  The methods for case ascertainment and 
for case and control recruitment for 2002-2005 have previously been described[12]; 
similar methods were used for 2006-2007.  Eligible cases were limited to English-
speaking women who had a residential telephone at the time of cancer diagnosis, because 
random digit dialing (RDD) was the method used to select controls.  Of 1,556 eligible 
cases identified, 1,170 (75.2%) were interviewed.  Tumor histologies were coded from 
pathology reports by the registry staff according to the third edition of the International 
Classification of Diseases for Oncology (ICD-O)[13]; for analysis, these were grouped 
into subtypes of serous, mucinous, endometrioid/clear cell, and other invasive tumors; 
and into serous, mucinous, and other borderline tumors. Control women (with at least one 
ovary and no history of ovarian cancer) were sampled via RDD within 5-year age 
categories, 1-year calendar intervals, and two (urban versus suburban/rural) county strata; 
list-assisted RDD methods were used for 2006-2007. We interviewed 1,584 control 
women, with a screening response proportion of 80.3% and an interview response 
proportion of 81.6%, for an overall response proportion (screening x interview) of 65.5%.  
For the current analyses, we restricted to women who had had at least one live birth (881 
cases and 1,345 controls). 
 
The study was approved by the Institutional Review Board of the Fred Hutchinson 
Cancer Research Center, and all women provided signed informed consent.  In-person 
interviews were undertaken with cases and controls. The women were asked to provide 
information that pertained to the time before diagnosis (for case patients) or before an 
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assigned comparable reference date (for control subjects). On average, the diagnosis or 
reference date was 9 months before interview for case patients and 11 months before 
interview for control subjects. The interview covered demographic and lifestyle 
characteristics; medical history; family and personal cancer history; and reproductive 
history. To aid recall, interviewers used a calendar to record life events and provided 
photographs of commonly used medicines including oral contraceptive and menopausal 
hormone preparations. Women were asked about each of their pregnancies in detail, 
including the outcome of the pregnancy. If the pregnancy resulted in a live birth women 
were asked about whether they had initiated breast feeding for that child. They were 
asked the duration of the feeding for each child and asked to recall how old the child was 
when he/she regularly began to take any food, formula or milk other than breast milk. 
Women with diagnosis/reference dates after 2005 were not asked about supplementary 
feeding.  
Statistical Analysis 
Only women who had had a live birth were included in the analysis and we only 
considered women who had breast fed a child for two weeks or more to have ever breast 
fed. Total duration of breast feeding was calculated by summing the duration of feeding 
after each birth (resulting in a live-born child). We calculated average duration of breast 
feeding per breast-fed child by dividing by the total duration of breast feeding by the 
number of children each woman reported having breast fed (considering multiple births 
as one). As we were also interested in durations of exclusive breast feeding we assessed 
the duration of breast-feeding up until the point at which the child regularly began to take 
food or milk other than breast milk, and summed that quantity across all children that a 
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woman breastfed. Similar to the approach described for total duration of breastfeeding, 
the duration of exclusive breast feeding was also divided by the number of children breast 
fed to give an average duration of exclusive breast feeding per breast-fed child. 
Odds ratios (OR) and 95% confidence intervals (95% CI) for the risk of epithelial ovarian 
cancer associated with various aspects of breast feeding were calculated using 
unconditional logistic regression. The reference group for all analyses was women who 
had had a live birth but had never breast fed a child for more than two weeks. Linear 
trends were assessed by the inclusion of the relevant continuous term in the model 
(excluding the women who had never breast fed).  
Subtype-specific analyses were conducted for the major tumor groups; invasive mucinous 
cancers (n=24) and borderline cancers of ‘other’ subtype (n=12) were excluded from 
these analyses because of the small case numbers.  
All results shown are adjusted for the frequency matching variables of age (5-year 
intervals), county of residence (two strata, as described above), and calendar year of 
diagnosis/reference date (1-year strata), as well as number of live births (categorical 
variables for 1, 2, 3, and 4 or more), duration of hormonal contraception (categorical 
variables of never users and users of <6, 6-59, 60-119, and ≥120 months), level of 
education (high school graduate or less, some college or technical college, college 
graduate, or post-graduate). Adjustment for other potential confounding variables 
(race/ethnicity, body mass index (BMI), age at menarche, history of breast cancer, family 
history of breast and/or ovarian cancer, smoking, tubal ligation, and hysterectomy) did 
not substantively change odds ratios. All analyses were conducted using SAS statistical 
software (SAS 9.2, SAS Institute Inc., Cary, NC, USA). 
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Results 
Table 1 shows demographic, lifestyle and reproductive factors of case and control women 
who had had at least one live birth. Compared to controls, women with ovarian cancer 
were more likely to report a personal history of breast cancer; have had fewer children; 
have a higher body mass index (BMI); have been a smoker; and to have a lower level of 
education. They were less likely to have taken hormonal contraceptives.   
Among women with at least one live birth, those who had ever breast fed a child for more 
than two weeks had a 22% decreased risk of ovarian cancer (OR=0.78, 95% CI, 0.64-0.96; 
Table 2) relative to those who had not and it appeared that the risk reduction was greatest 
for those with the longest total duration of breast feeding (e.g., OR=0.70, 95%CI 0.53-
0.93, for18 months or more of breast feeding versus never breast fed (Table 2)). When we 
looked at the longest individual episode of breast feeding women reported, we found that 
those who had breast fed at least one child for 18 months or more had a 43% reduction in 
risk compared to those who never breast fed (p-trend per month of breast feeding among 
women who had ever breast fed =0.1).  Similarly, those who on average breast fed each 
child for 18 months or more had a 44% reduction in risk compared to those who never 
breast fed (OR=0.56, 95% CI 0.32-0.98).  
As noted above, assessment of supplementary feeding was limited to cases and controls 
with diagnosis/reference dates 2002-2005, representing approximately 60% of the women 
who breast fed for more than 2 weeks (Table 2). We found no convincing evidence that 
the timing of introduction of supplementary feeds had an impact on the overall effects of 
breast feeding.  
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We found no material difference in the effect of breast feeding between women who 
breast fed their last child and those who did not; or between those who used hormonal 
contraceptives at some stage during lactation and those who did not (data not shown).  
Also, our overall results were broadly similar when women were considered in strata of 
live births and the interaction between the number of live births and having ever breast 
fed was not statistically significant (Table 3). Amongst women with only one live birth, 
18 months or more of breast feeding was associated with an almost 70% reduction in 
ovarian cancer risk. An average duration of six or more months of breast feeding per 
child was associated with a 27-35% reduction in risk of ovarian cancer in women with 
one, two and four births but was not apparent amongst women with three births. The 
number of women in categories beyond 4 live births was too small to produce meaningful 
estimates. 
We also stratified our analyses by hormonal contraceptive use, age (less than or greater 
than 50) and histological subtype (Tables 4 and 5).  There was a suggestion that the 
effects of breast feeding were more pronounced amongst women who had ever used 
hormonal contraception (e.g., OR=0.981, 95%CI 0.962-1.000) per month of average 
breast feeding per child breast fed amongst contraceptive users compared with 
OR=1.002, 95%CI 0.961-1.045 for never users of hormonal contraceptives) but the 
interaction terms was not significant (p=0.6). Our results also suggest that longer 
durations of breast feeding are associated with greater risk reduction for invasive 
endometrioid/clear cell ovarian cancer compared to invasive serous cancer (OR per 
month of average breast feeding per child breast fed = 0.944, 95%CI 0.903-0.987  for 
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endometrioid/clear cell versus OR=0.989, 95%CI 0.965-1.013 for serous invasive 
cancers.  
Discussion 
Our results suggest that amongst parous women, ever breast feeding and longer durations 
of breast feeding per breast-fed child are associated with decreased risks of ovarian 
cancer independent of numbers of births. We had expected that exclusive breast feeding 
would confer greater risk reduction than breast feeding after supplementary food/milk 
was introduced but our results did not support that hypothesis. We did however find some 
evidence that the effects of breast feeding might vary according to ever-use of hormonal 
contraceptives and histological subtype of ovarian cancer. 
Strengths of this study include the large number of cases and controls, its population-
based design, the relatively high response proportions amongst both cases and controls 
and the detailed information available about women’s breast feeding practices and 
potential confounding factors. A weakness is that all the information was recalled, often 
from many years in the past, so it is likely that there is some error in the estimates. 
However, highly structured interviews and lifetime calendars were used to aid recall and, 
as the association between breast feeding and ovarian cancer is not well established or 
widely known, it is likely that any error would be non-differential.  
Although the World Cancer Research Fund report from 2007[14] concluded that ‘there is 
limited evidence suggesting that lactation protects against ovarian cancer’, a meta-
analysis of nine case-control studies reported a 30% reduction in risk for women who had 
ever breast fed.[4]  Also, as reviewed by Danforth and colleagues, [7] most other more 
recently published population-based studies have found inverse associations with breast 
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feeding [5,15,7] although not all results have been statistically significant or shown trends 
of decreasing risk with increasing duration of lactation. Since the Danforth paper [7] a 
further three studies have investigated this association. A Danish study of borderline 
ovarian tumors found an overall reduction in risk of around 2% per month of breast 
feeding.[6] While we found some suggestion of risk reduction for this tumor group, our 
results were not statistically significant possibly reflecting the much higher proportions of 
never-breast feeders in our study (26% amongst our controls versus 6% in the Danish 
study). An Australian study reported a similar risk reduction for ever breast feeding and 
somewhat stronger inverse associations with total duration and average duration (per 
birth) of breast feeding (1.4% and 3.5% per month respectively) compared to the current 
study.[8] Again the proportion of never breast feeders was lower in that study (18%). 
That study also considered duration of individual episodes of breast feeding and these 
analyses suggested that breast feeding a child beyond 12 months conferred no additional 
risk reduction. In contrast, our results for the longest episode of breast feeding, for breast 
feeding amongst women with only one child and for average duration per child breast fed 
suggest that risk reduction continues for episodes of 18 months of lactation and beyond. 
Finally a recent US-based case-control study found a decreased risk of ovarian cancer for 
ever breast feeders but little evidence of further risk reduction with increasing duration of 
lactation (of note, the proportion of never breast feeders amongst controls in that study 
was 46%).[9] These authors also reported that the risk reducing effect of breast feeding 
was restricted to women who breast fed their last child - a finding that we did not 
replicate. They did however find, as we did, that the risk reduction associated with breast 
feeding was greatest for the combined group of endometrioid and clear cell cancers. A 
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specific benefit for endometrioid or clear cell cancers has now been reported by five 
[16,17,7,9] of nine studies (including the present study), that have investigated the 
subtype effects. A pooled analysis with the power to investigate the subtypes individually 
is required to definitively determine whether breast feeding has particular risk-reducing 
effects for endometrioid and clear cell cancers but such an association is biologically 
plausible. Endometriosis is a likely precursor lesion for both subtypes [18] and 
endometriosis is effectively treated with drugs which induce a profound hypo-estrogenic 
state; breast feeding can have a similar effect. Indeed, breast feeding has been found to 
reduce the risk of endometriosis amongst parous women. [19]  
An overall effect of breast feeding is also biologically plausible. Breast feeding causes 
gonadatrophin suppression leading to low estrogen levels and anovulation with a 
resulting period of lactational amenorrhea (LAM) and should thus protect the ovary from 
most factors postulated to have a strong causative role in ovarian cancer development. 
[20] We did not directly ask about the duration of LAM, although we had information 
about factors such as supplementary feeding and maternal body mass index around the 
time of child-bearing, which can influence its duration[3,21]. In our study the timing of 
introduction of supplementary feeds did not appear to influence ovarian cancer risk, 
however if extra food merely supplements breast milk intake without reducing it then 
gonadatrophin suppression and anovulation may persist [21,22]. The final indicator of 
duration of LAM that we have is duration of breast feeding itself. Duration of episodes of 
breast feeding is likely highly correlated with duration of LAM and our results do 
indicate that longer episodes of breast feeding result in lower risks of ovarian cancer.  
Although recall difficulties may be problematic, direct assessment of the duration of 
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lactational amenorrhea and other practices associated with its duration (e.g. night 
feeding) may help us understand how the benefits of breast feeding for ovarian cancer 
reduction might best be achieved.  
In conclusion we have found that, amongst women who have had the opportunity to 
breast feed, ever breast feeding and increasing durations of episodes of breast feeding are 
associated with a decrease in the risk of ovarian cancer. In line with the general advice 
from the US National Institute of Child Health and Human Development [23] our results 
indicate maternal benefits for breast feeding to 12 months and beyond.  
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Table 1. Demographic, lifestyle and reproductive factors amongst case and control 
women with at least one live birth who participated in a case-control study of epithelial 
ovarian cancer, in Washington State, USA 2002-2007 
 Cases 
N=881 
N (%) 
Controls 
N=1345 
N(%) 
p-value  
Age at diagnosis or reference date (years) 
 35-44 
 45-54 
 55-64 
 65-74 
  99 (11.2) 
263 (29.9) 
326 (37.0) 
193 (21.9) 
151 (11.2) 
381 (28.3) 
470 (34.9) 
343 (25.5) 
0.3  
Race/ethnicity 
 White, non-Hispanic 
 Nonwhite, non-Hispanic 
 Hispanic 
 
790 (89.7) 
  59 (6.7) 
  32 (3.6) 
 
1218 (90.6) 
    92 (6.8) 
    35 (2.6) 
 
0.1 
 
Duration of use of hormonal contraceptives (months)   
 Never used 
 <6 
 6 to <59  
 60 to <119 
 ≥120 
206 (23.4) 
  77   (8.8) 
325 (36.9) 
157 (17.8) 
115 (13.1) 
231 (17.2) 
  98 (7.3) 
509 (37.8) 
275 (20.5) 
232 (17.3) 
0.0005  
Number of live births 
 1 
 2 
 3 
 ≥4 
 
187 (21.2) 
344 (39.1) 
209 (23.7) 
141 (16.0) 
 
213 (15.8) 
539 (40.1) 
351 (26.1) 
242 (18.0) 
 
0.01 
 
Tubal ligation 
 No 
 Yes 
 
673 (76.4) 
208 (23.6) 
 
994 (73.9) 
351 (26.1) 
 
0.2 
 
Family history of breast and ovarian cancera   
 None 
 Breast cancer only 
 Ovarian cancer only 
 Breast and ovarian cancer 
510 (58.3) 
264 (30.2) 
  59 (6.7) 
  42 (4.8) 
800 (60.1) 
432 (32.4) 
  60 (4.5) 
  40 (3.0) 
0.01  
Prior breast cancer 
 No 
 Yes 
 
818 (92.9) 
63 (7.2) 
 
1278 (95.0) 
 67 (5.0) 
 
0.03 
 
Body mass index at age 30 (kg/m2)    
 <18.5 
 18.5-24.9 
 25-29.9 
 ≥30 
  45 (5.1) 
657 (75.3) 
110 (12.6) 
  61 (7.0) 
    91 (6.8) 
1031 (77.3) 
  139 (10.4) 
    72 (5.4) 
0.07  
Smoking status 
 Never  
 
419 (47.6) 
 
717 (53.4) 
 
0.02 
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 Former 
 Current 
346 (39.3) 
116 (13.2) 
459 (34.2) 
168 (12.5) 
Level of Education 
 High School grad or less 
 Some college or tech. 
 College graduate 
 Post graduate 
 
267 (30.4) 
343 (39.0) 
180 (20.5) 
  89 (10.1) 
 
325 (24.2) 
507 (37.8) 
301 (22.4) 
210 (15.6) 
 
0.0001 
 
a family history was defined as having an affected first or second degree relative. 
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Table 2. Adjusteda odds ratios and 95% confidence intervals for the association between breast 
feeding and invasive and borderline epithelial ovarian cancer amongst women with at least one 
live birth 
 Cases 
N=881 
N (%) 
Controls 
N=1345 
N (%) 
 
 
OR (95% CI) 
Ever breast fed 
 Nob 
 Yes 
286 (32.5) 
595 (67.5)    
356 (26.5)
988 (73.5)
1.00 
0.78 (0.64-0.96) 
Total duration of breast feeding (months) 
 Noneb 
 <6 
 6 to <18 
 ≥18 
 Per month 
286 (32.5) 
217 (24.6) 
210 (23.8) 
168 (19.1) 
356 (26.5)
335 (24.9)
334 (24.9)
319 (23.7)
1.00 
0.80 (0.63-1.02) 
0.81 (0.63-1.05) 
0.70 (0.53-0.93) 
0.997 (0.991-1.003) 
 
p=0.3 
Longest individual episode of breast feeding (months) 
 Noneb 
 <3 
 3-<6 
 6-<12 
 12-<18 
 ≥18 
 Per month 
286 (32.5) 
157 (17.8) 
116 (13.2) 
168 (19.1) 
  98 (11.1) 
  56 (6.4) 
356 (26.5)
253 (18.8)
183 (13.6)
268 (19.9)
159 (11.8)
125 (9.3) 
1.00 
0.81 (0.62-1.06) 
0.77 (0.57-1.04) 
0.81 (0.62-1.07) 
0.81 (0.58-1.13) 
0.57 (0.39-0.84) 
0.990 (0.976-1.003) p=0.1 
Average duration of breast feeding per child breast fed(months) 
 Noneb 
 <6 
 6 to< 9 
 9 to<12 
 12 to <18 
 ≥18 
 Per month 
286 (32.5) 
341 (38.7) 
123 (14.0) 
  71 (8.1) 
  37 (4.2) 
  23 (2.6) 
 
356 (26.5)
537 (40.0)
213 (15.9)
116 (8.6) 
  76 (5.7) 
  46 (3.4) 
 
1.00 
0.81 (0.65-1.01) 
0.76 (0.55-1.01) 
0.80 (0.55-1.16) 
0.65 (0.41-1.02) 
0.56 (0.32-0.98) 
0.985 (0.968-1.002) 
 
 
 
 
 
 
P=0.09 
Average duration of exclusive breast feeding (months) in strata of average months of 
breast feeding per child breast fedc 
No breast feedingb 
Average duration/child b.f 0-6mths 
 <3  mths exclusive 
 3-≤6  mths exclusive 
Average duration/child b.f >6-12mths
 <3 mths exclusive 
 3-≤6 mths exclusive 
 >6  mths exclusive 
286 (44.6) 
 
180 (28.1) 
  80 (12.5) 
 
  20 (3.1) 
  65 (10.1) 
  10 (1.6) 
356 (33.5)
 
344 (32.3)
144 (13.5)
 
  57 (5.4) 
135 (12.7)
  28 (2.6) 
1.00 
 
0.83 (0.64-1.08) 
0.86 (0.61-1.21) 
 
0.59 (0.34-1.04) 
0.80 (0.55-1.16) 
0.57 (0.27-1.22) 
 
a Adjusted for matching variables, reference year, education (high school graduate or less, some 
college or tech, college graduate, post-graduate), number of live births (1, 2, 3 or  ≥4), duration of 
hormonal contraception (never used, <6 mths, 6 mths to <5 years, 5 to <10 yrs, 10 yrs or more). 
bWomen who never breast fed at least one child for 2 or more weeks were included in this group 
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c Only women recruited between 2002 and 2005 provided information about timing of introduction 
of supplementary feeds. 
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Table 3. Adjusteda odds ratios and 95% confidence intervals for the association between breast feeding  and ovarian 
cancer in strata of number of live births 
   One Birth 
Case= 187 (21.2) 
Cont=213 (15.8) 
Two Births 
Case= 344 (39.1) 
Cont= 539 (40.1) 
Three Births 
Case=209 (23.7)  
Cont=351 (26.1) 
Four Births 
Case=87 (9.9) 
Cont=150 (11.2) 
                         Odds ratios and 95% confidence intervals 
  
Ever breast fed      
 Nob 
 Yes 
  1.00 
0.72 (0.44-1.15) 
1.00 
0.75 (0.54-1.04) 
1.00 
0.88 (0.57-1.35) 
1.00 
0.83 (0.42-1.63) 
Total duration of breast feeding (months)    
 Noneb 
 <6 
 6 to <18 
 ≥18 
Per month 
  1.00 
0.70 (0.41-1.20) 
0.87 (0.48-1.57) 
0.32 (0.11-0.90) 
0.975 (0.942-1.010)
1.00 
0.96 (0.65-1.42) 
0.57 (0.38-0.85) 
0.72 (0.46-1.14) 
0.992(0.977-1.007) 
1.00 
0.69 (0.41-1.17) 
1.06 (0.62-1.80) 
1.01 (0.57-1.79) 
1.000 (0.992-1.007)
1.00 
0.39 (0.16-0.96) 
1.89 (0.81-4.40) 
0.73 (0.31-1.70) 
0.998(0.982-1.014) 
Average duration of breast feeding per child breast fed(months)  
 Noneb 
 <6 
 ≥6 
 Per month 
  1.00 
0.70 (0.41-1.21) 
0.73 (0.42-1.29) 
0.975 (0.942-1.010)
1.00 
0.81 (0.57-1.15) 
0.66 (0.44-0.98) 
0.983 (0.955-1.012) 
1.00 
0.81 (0.52-1.28) 
1.05 (0.61-1.82) 
0.990 (0.951-1.032) 
1.00 
1.94 (0.46-1.93) 
0.65 (0.28-1.50) 
0.996 (0.933-1.063) 
a Adjusted for matching variables, reference year, education (high school graduate or less, some college or tech, college graduate, post- 
graduate), duration of hormonal contraceptive use (never used, <6 months, 6months to <5 years, 5 to <10 years, 10 years or more) 
bWomen who breast fed for less than 2 weeks were included in this group 
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Table 4.  Adjusteda odds ratios and 95% confidence intervals for the association between breast feeding and epithelial ovarian cancer 
stratified by a) ever-use of hormonal contraceptives, b) age greater or less than 50 years 
 Never used OCs Ever-used OCs Age <50 Age ≥50 
 Case=206 (23.4) 
Cont=231 (17.2) 
Case=674 (76.6) 
Cont=1114(82.8) 
Case=214 (24.3) 
Cont=327 (24.3) 
Case=667 (75.7) 
Cont=1018 (75.7) 
 Odds ratios and 95% confidence intervals 
Ever breast fed    
 Nob 
 Yes 
 
1.00 
1.10 (0.70-1.72) 
1.00 
0.71 (0.56-0.90) 
1.00 
0.81 (0.48-1.34) 
1.00 
0.77 (0.61-0.96) 
Total duration of breast feeding (months)   
 Noneb 
 <6 
 6 to <18 
 ≥18 
Per mth 
1.00 
1.14 (0.66-1.97) 
1.33 (0.72-2.43) 
0.82 (0.44-1.54) 
1.003 (0.990-1.017) 
1.00 
0.73 (0.55-0.96) 
0.73 (0.55-0.96) 
0.65 (0.47-0.90) 
0.994 (0.987-1.002)
1.00 
0.97 (0.53-1.76) 
0.79 (0.44-1.41) 
0.68 (0.38-1.24) 
0.994 (0.982-1.006)
1.00 
0.75 (0.58-0.98) 
0.83 (0.63-1.10) 
0.70 (0.50-0.98) 
0.998 (0.991-1.005)
Average duration of breast feeding  per child breast fed (months)
 Noneb 
 <6 
 ≥6 
Per mth 
1.00 
1.16 (0.72-1.86) 
1.03 (0.58-1.83) 
1.002 (0.961-1.045) 
1.00 
0.74 (0.58-0.95) 
0.66 (0.50-0.87) 
0.981 (0.962-1.000)
1.00 
0.96 (0.56-1.66) 
0.66 (0.38-1.16)   
0.983 (0.956-1.011) 
1.00 
0.77 (0.61-0.98) 
0.76 (0.57-1.02) 
0.985 (0.963-1.008)
a Adjusted for matching variables, reference year, education (High School graduate or less, some college or tech, college graduate, post 
graduate), duration of hormonal contraceptive use (never used, <6 months, 6months to <5 years, 5 to <10 years, 10 years or more) 
b Women who breast fed for less than 2 weeks were included in this group 
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Table 5 Adjusteda odds ratios and 95% confidence intervals for the association between breast feeding and epithelial ovarian cancer by 
histological subtype  
 Invasive Borderline 
   All Invasive 
N=658 
  OR (95% CI) 
Serous  
N=405 
OR (95% CI) 
Endo/ccc 
N=122 
OR (95% CI) 
Other 
N=107 
OR (95% CI) 
All borderline 
N=223 
OR (95% CI) 
Serous 
N=121 
OR (95% CI) 
Mucinous 
N=90 
OR (95% CI) 
Ever breast fed 
Nob 
Yes 
 
1.00 
0.80 (0.64-1.00) 
1.00 
0.85 (0.65-1.11) 
1.00 
0.73 (0.46-1.14) 
1.00 
0.71 (0.46-1.12) 
1.00 
0.70 (0.50-0.99) 
1.00 
0.73 (0.46-1.14) 
1.00 
0.68 (0.41-1.13) 
Total duration of breast feeding (months)
Noneb 
<6 
6 to <18 
≥18 
Per mth 
1.00 
0.82 (0.63-1.07) 
0.86 (0.66-1.13) 
0.65 (0.47-0.89) 
0.993 (0.986-1.001) 
1.00 
0.80 (0.58-1.10) 
0.95 (0.69-1.32) 
0.80 (0.55-1.16) 
0.999 (0.991-1.007)
1.00 
0.99 (0.60-0.64) 
0.61 (0.34-1.09) 
0.43 (0.22-0.86) 
0.974 (0.954-
0.995) 
1.00 
0.72 (0.42-1.23) 
0.87 (0.50-1.51) 
0.45 (0.21-0.94) 
0.979 (0.957-1.001) 
1.00 
0.70 (0.46-1.06) 
0.66 (0.42-1.02) 
0.77 (0.49-1.22) 
1.004 (0.994-1.014)
1.00 
0.71 (0.41-1.23) 
0.71 (0.41-1.25) 
0.76 (0.42-1.38) 
1.00 (0.986-1.014)
1.00 
0.75 (0.41-1.38) 
0.51 (0.25-1.02) 
0.76 (0.39-1.48) 
1.008 (0.994-1.022) 
Average duration of breast feeding per child breast fed (months) 
Noneb 
<6 
≥6 
Per mth 
1.00 
0.84 (0.66-1.07) 
0.72 (0.55-0.95) 
0.975 (0.955-0.995) 
1.00 
0.86 (0.64-1.14) 
0.84 (0.61-1.17) 
0.989 (0.965-1.013)
1.00 
0.89 (0.55-1.44) 
0.48 (0.27-0.87) 
0.944 (0.903-0.987)
1.00 
0.72 (0.44-1.18) 
0.70 (0.39-1.23) 
0.970 (0.926-1.016) 
1.00 
0.70 (0.48-1.02) 
0.71 (0.47-1.07) 
1.003 (0.978-1.028)
1.00 
0.77 (0.48-1.26) 
0.65 (0.38-1.12) 
0.997 (0.965-1.030)
1.00 
0.66 (0.38-1.16) 
0.70 (0.38-1.30) 
1.010 (0.974-1.048) 
a Adjusted for matching variables, reference year, education (High School graduate or less, some college or tech, college graduate, 
post graduate), number of live births (1, 2, 3 or 4 or more) duration of hormonal contraceptive use (never used, <6 months, 6months to 
<5 years, 5 to <10 years, 10 years or more) 
b Women who breast fed for less than 2 weeks were included in this group 
 
